Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleCardiovascular

Apixaban Inhibits Cerebral Microembolic Signals Derived from Carotid Arterial Thrombosis in Rabbits

Xueping Zhou, Weizhen Wu, Lin Chu, David E. Gutstein, Dietmar Seiffert and Xinkang Wang
Journal of Pharmacology and Experimental Therapeutics September 2016, 358 (3) 405-412; DOI: https://doi.org/10.1124/jpet.116.234575
Xueping Zhou
Cardiometabolic Disease Biology (X.Z., W.W., D.E.G., D.S., X.W.) and Discovery Pharmaceutical Sciences (L.C.), Merck Research Laboratories, Kenilworth, New Jersey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Weizhen Wu
Cardiometabolic Disease Biology (X.Z., W.W., D.E.G., D.S., X.W.) and Discovery Pharmaceutical Sciences (L.C.), Merck Research Laboratories, Kenilworth, New Jersey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lin Chu
Cardiometabolic Disease Biology (X.Z., W.W., D.E.G., D.S., X.W.) and Discovery Pharmaceutical Sciences (L.C.), Merck Research Laboratories, Kenilworth, New Jersey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David E. Gutstein
Cardiometabolic Disease Biology (X.Z., W.W., D.E.G., D.S., X.W.) and Discovery Pharmaceutical Sciences (L.C.), Merck Research Laboratories, Kenilworth, New Jersey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dietmar Seiffert
Cardiometabolic Disease Biology (X.Z., W.W., D.E.G., D.S., X.W.) and Discovery Pharmaceutical Sciences (L.C.), Merck Research Laboratories, Kenilworth, New Jersey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xinkang Wang
Cardiometabolic Disease Biology (X.Z., W.W., D.E.G., D.S., X.W.) and Discovery Pharmaceutical Sciences (L.C.), Merck Research Laboratories, Kenilworth, New Jersey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Article Information

vol. 358 no. 3 405-412
DOI 
https://doi.org/10.1124/jpet.116.234575
PubMed 
27384071

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Received April 22, 2016
  • Accepted June 29, 2016
  • Published online August 1, 2016.

Article Versions

  • Earlier version (July 6, 2016 - 11:12).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2016 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Xueping Zhou,
  2. Weizhen Wu,
  3. Lin Chu,
  4. David E. Gutstein,
  5. Dietmar Seiffert, and
  6. Xinkang Wang
  1. Cardiometabolic Disease Biology (X.Z., W.W., D.E.G., D.S., X.W.) and Discovery Pharmaceutical Sciences (L.C.), Merck Research Laboratories, Kenilworth, New Jersey
  1. Address correspondence to:
    Dr. Xinkang Wang, Cardiometabolic Disease Biology, Merck Research Laboratories, 2015 Galloping Hill Road, Kenilworth, NJ, 07033. E-mail: xinkang.wang{at}merck.com or wangxk2000{at}yahoo.com
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: July 2016 to May 2023

AbstractFullPdf
Jul 2016202964
Aug 201610083062
Sep 20161161916
Oct 201634711
Nov 2016281717
Dec 201671114
Jan 20172986
Feb 20172628
Mar 201730511
Apr 20173426
May 201722413
Jun 201730116
Jul 20173716
Aug 20178216
Sep 20176278
Oct 2017101816
Nov 2017202822
Dec 201712182
Jan 2018102312
Feb 2018131422
Mar 201842320
Apr 201852316
May 201891315
Jun 201831511
Jul 20188124
Aug 20183208
Sep 201821617
Oct 201872116
Nov 2018121117
Dec 201821518
Jan 20196518
Feb 20191817
Mar 2019201617
Apr 201921423
May 201931425
Jun 20193626
Jul 20191722
Aug 201911219
Sep 201941416
Oct 201931318
Nov 201931817
Dec 201931918
Jan 202031014
Feb 202041511
Mar 202051621
Apr 2020058
May 20200928
Jun 20200422
Jul 202021617
Aug 20201711
Sep 20204512
Oct 20202107
Nov 20201712
Dec 20204914
Jan 202141314
Feb 20213918
Mar 202181714
Apr 202121913
May 202142023
Jun 20211118
Jul 20212915
Aug 20213524
Sep 20214711
Oct 20210923
Nov 202121421
Dec 2021149
Jan 20221732
Feb 20223613
Mar 202211515
Apr 20221821
May 20220619
Jun 20223713
Jul 20221716
Aug 20221544
Sep 202255413
Oct 20222434
Nov 20223415
Dec 20222024
Jan 20232813
Feb 20231224
Mar 20233616
Apr 20232325
May 202321114

PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 358 (3)
Journal of Pharmacology and Experimental Therapeutics
Vol. 358, Issue 3
1 Sep 2016
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Apixaban Inhibits Cerebral Microembolic Signals Derived from Carotid Arterial Thrombosis in Rabbits
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleCardiovascular

Apixaban Inhibits Cerebral Microembolic Signals

Xueping Zhou, Weizhen Wu, Lin Chu, David E. Gutstein, Dietmar Seiffert and Xinkang Wang
Journal of Pharmacology and Experimental Therapeutics September 1, 2016, 358 (3) 405-412; DOI: https://doi.org/10.1124/jpet.116.234575

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleCardiovascular

Apixaban Inhibits Cerebral Microembolic Signals

Xueping Zhou, Weizhen Wu, Lin Chu, David E. Gutstein, Dietmar Seiffert and Xinkang Wang
Journal of Pharmacology and Experimental Therapeutics September 1, 2016, 358 (3) 405-412; DOI: https://doi.org/10.1124/jpet.116.234575
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Material and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Prognostic role of contraindcated drugs in decompensated HF.
  • Vericiguat: Nonclinical Cardiovascular Assessment
  • The Effect of Dexmedetomidine on PAH Improvement
Show more Cardiovascular

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics